SEC
SlamSEC
SearchBrowseEarnings

Estrella Immunopharma, Inc.

Nasdaq:ESLANasdaq:ESLAW
Biological Products, (No Diagnostic Substances)·EMERYVILLE, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Governanceproxy statements · beneficial ownership

Proxy Statements

6 shown
FiledFormDescription
7/26/23DEFA14ADEFINITIVE ADDITIONAL MATERIALS→
7/12/23DEFA14ADEFA14A→
6/16/23DEF 14ADEF 14A→
5/25/23PRE 14APRE 14A→
12/6/22DEF 14ADEF 14A→
11/25/22PRE 14APRE 14A→

Ownership Filings

40 shown
FiledFormDescription
10/1/2533→
2/14/2544→
2/14/2544→
8/23/2433→
10/30/23SC 13DSCHEDULE 13D→
10/10/2333→
↓
CEO
Liu Cheng
CFO
Xu Jiandong